You are here

Article Text

Article menu
Images in...
Congenital hyperinsulinism: [18F]DOPA PET/CT scan of a focal lesion in the head of the pancreas
Free
  1. R R Kapoor1,
  2. C Gilbert1,
  3. K Mohnike2,
  4. O Blankenstein3,
  5. F Fuechtner3,
  6. K Hussain1
  1. 1
    London Centre for Paediatric Endocrinology and Metabolism, Great Ormond Street, Hospital for Children NHS Trust, London, and The Institute of Child Health, London, UK
  2. 2
    Department of Paediatrics and Neonatology, O.-v.-Guericke-University Magdeburg, Germany
  3. 3
    Institute of Experimental Paediatric Endocrinology, Charité-Universitätsmedizin Berlin, Germany
  1. K.Hussain{at}ich.ucl.ac.uk

https://doi.org/10.1136/bcr.2007.121178

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Congenital hyperinsulinism (CHI) is a cause of severe hypoglycaemia in the neonatal period.1 The histological differentiation of CHI into focal and diffuse disease has radically changed the surgical management of patients with the disease.2 Correct localisation and limited excision of the focal lesion results in complete cure of the patient. Recent advances in fluorine-18 l-3,4-dihydroxyphenylalanine ([18F]DOPA) …

    View Full Text